Entera Bio share price logo

Entera Bio

NASDAQ: ENTX

Small Cap

$2.86

-0.03

(-1.04%)

as on

Entera Bio Stock Performance

as on October 3, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $2.82
    $2.90
    downward going graph

    1.40%

    Downside

    1.40%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.91
    $4.20
    downward going graph

    68.18%

    Downside

    46.85%

    Upside

    downward going graph

Entera Bio share price movements today

Previous Close
$2.89
Open
$2.89
Volume
307.5K
Market Cap
$500.4M
Day's Low - High
$2.82 - $2.90
52 Week Low - High
$0.91 - $4.20

Entera Bio Historical Returns

1 Month Return
-3.05 %
3 Month Return
+ 72.29 %
1 Year Return
+ 50.53 %
3 Year Return
+ 297.22 %
5 Year Return
-40.29 %

Entera Bio Stock Fundamentals & Key Indicators

Check Entera Bio market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$500.4M

EPS (TTM)

-0.3467

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-8.31

Industry PE ratio

-6.16

PEG Ratio

0.06

EBITDA

-14.3M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-147.19%

Entera Bio vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Entera Bio with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Entera Bio image
Entera Bio
StrongBuy$500.4M-40.29%-8.310.00%0.00%
Revolution Medicines image
Revolution Medicines
StrongBuy$44.1B609.62%-23.340.00%0.00%
Moderna image
Moderna
Neutral$75.4B-44.29%-24.08-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$132.5B180.98%30.1986.04%0.00%
Regeneron image
Regeneron
Buy$78.1B28.80%17.6784.86%0.50%

Stock Returns calculator for Entera Bio Stock including INR - Dollar returns

The Entera Bio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Entera Bio investment value today

Current value as on today

₹1,63,387

Returns

₹63,387

(+63.39%)

Returns from Entera Bio Stock

₹50,526 (+50.53%)

Dollar Impact

₹12,861 (+12.86%)

Analyst Recommendation on Entera Bio Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Entera Bio. Average target price of $9.75

Entera Bio Share Price Target

Get share price movements and forecasts by analysts on Entera Bio.

What analysts predicted

70.67%UPSIDE

Target Price

$9.75

Current Price

$2.86

Analyzed by

3 Analysts

High

$11

Target

$9.75

Low

$9

Entera Bio target price $9.75, a slight upside of 70.67% compared to current price of $2.86. According to 3 analysts rating.

Indian Investors' Interest in Entera Bio Stock

Search interest for Entera Bio Stock has decreased by -65% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-65% versus previous 30 day period

Entera Bio Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
0
0
0
0
-
-
-
-
-
Gross Profit
0
0
-
-
-
-
0
-
0
-
Operating Income
-2
-2
-3
-2
-2
-2
-3
-3
-3
-4
EBITDA
-2
-2
-3
-2
-2
-2
-3
-3
-3
-4
Interest Expense
-
-
-
0
-
-
-
-
-
2
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-2
-2
-3
-2
-2
-2
-3
-3
-3
-7
Income Tax Expense
-
-
-6
0
-
-
-
-
-
-
Net Income
-2
-2
-3
-2
-2
-2
-3
-3
-3
-7
Net Profit Margin
0.00%
15.79%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Entera Bio Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Mar 2023
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
0
0
0
0
0
-
0
0
Gross Profit
0
0
0
0
0
0
0
0
-
Operating Income
11
-10
-11
-11
-12
-13
-8
-9
-11
EBITDA
-11
-10
-10
-11
-12
-12
-8
-9
-11
Interest Expense
-
-
0
0
0
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-11
-10
-10
-11
-12
-12
-8
-9
-11
Income Tax Expense
0
-
-
0
0
0
0
0
-
Net Income
-11
-10
-10
-11
-12
-13
-8
-9
-11
Net Profit Margin
0.00%
100.00%
-89.83%
17.81%
34.68%
-23.13%
0.00%
4.97%
0.00%

Entera Bio Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-2
-2
-3
-2
-2
-2
-3
-3
-3
-7
Operating Cash Flow
-1
-1
-2
-1
-1
-1
-2
-2
-3
-3
Investing Cash Flow
-
-
-
0
0
0
0
0
-
0
Financing Cash Flow
0
1
0
3
13
0
0
0
0
9
Change in Cash
-1
0
-2
1
11
-1
-2
-1
-2
6

Entera Bio Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Mar 2023
Dec 2023
Dec 2024
Dec 2025
Net Income
-11
-10
-10
-11
-12
-13
-8
-9
-11
Operating Cash Flow
-4
-9
-8
-10
-9
-12
-7
-6
-7
Investing Cash Flow
1
-4
3
0
0
0
0
0
0
Financing Cash Flow
11
9
12
4
25
0
6
4
13
Change in Cash
7
-4
7
-6
16
-12
-1
-2
6

Global Institutional Holdings in Entera Bio

Check out the Institutions with significant holdings in Entera Bio.

Funds
Holdings
Fidelity Concord Street Trust
0.01%

Entera Bio News & Key Events

  • img

    Today's Timeline - 09 February

    Mon, 09:31 PM

    -

    Entera Bio appoints Geno J. Germano as Chairman of the Board, effective February 4, 2026.

Insights on Entera Bio

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, ENTX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, ENTX stock has moved up by 72.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 566.9% return, outperforming this stock by 516.4%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -3.01M → -7.31M (in $), with an average decrease of 62.4% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 82.0K → 42.0K (in $), with an average decrease of 48.8% per quarter

About Entera Bio

Entera Bio Ltd. is a biopharmaceutical firm in the clinical development phase, dedicated to creating and marketing oral medications composed of large molecules, addressing medical conditions that currently lack adequate treatments. Its primary experimental drugs are EB612, currently undergoing Phase II clinical assessment for hypoparathyroidism, and EB613, which has concluded Phase II studies for osteoporosis and is now in Phase I trials for treating non-healing bone fractures. Furthermore, the company holds a collaborative research and licensing pact with Amgen Inc. aimed at identifying and advancing potential therapeutic compounds for inflammatory conditions and other grave ailments. Established in 2009, Entera Bio Ltd. operates from its headquarters in Jerusalem, Israel.
OrganisationEntera Bio
HeadquartersKiryat Hadassah Minrav Building, Jerusalem, JM, 9112002, IL
IndustryBiotechnology
CEOMiranda J. Toledano

Key Management of Entera Bio

Name

Title

Ms. Dana Yaacov-Garbeli CPA

Chief Financial Officer

Ms. Cherin Smith

Executive VP & Head of Clinical Operations

Dr. Constantin Itin Ph.D., R.Ph.

Head of Biopharmaceutics & Bioanalytics

Mr. Riccardo Paolo Camisasca M.D.

Chief Medical Officer

Dr. Hillel Galitzer M.B.A., Ph.D.

Chief Operating Officer

Dr. Gregory Burshtein Ph.D.

Chief of Research & Development

Dr. Rachel B. Wagman

Chief Clinical Advisor

Ms. Michele McDermott

MD & EVP of Medical Affairs

Ms. Miranda J. Toledano M.B.A.

CEO & Director

FAQs

What is Entera Bio share price today?

Entera Bio share price today is $2.86 as on at the close of the market. Entera Bio share today touched a day high of $2.90 and a low of $2.82.

What is the 52 week high and 52 week low for Entera Bio share?

Entera Bio share touched a 52 week high of $4.20 on and a 52 week low of $0.91 on . Entera Bio stock price today i.e. is closed at $2.86,which is 31.90% down from its 52 week high and 214.29% up from its 52 week low.

What is Entera Bio's market capitalisation today?

Entera Bio market capitalisation is $0.00T as on .

How to invest in Entera Bio Stock (ENTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Entera Bio on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Entera Bio Stock (ENTX) from India?

Indian investors can start investing in Entera Bio (ENTX) shares with as little as ₹96.300003051758 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.00 in Entera Bio stock (as per the Rupee-Dollar exchange rate as on ). Based on Entera Bio share’s latest price of $2.86 as on October 3, 2026 at 8:45 am IST, you will get 3.4965 shares of Entera Bio. Learn more about fractional shares .

What are the returns that Entera Bio has given to Indian investors in the last 5 years?

Entera Bio stock has given -40.29% share price returns and 28.69% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?